Latest Utilities News

Atturra Limited reported a $4 million loss for the half-year ending December 2025, even as revenue jumped nearly 28%. The company’s recent acquisition of Blue Connections adds complexity to its financial outlook.

Artrya Limited reported a 44% increase in its half-year loss to $10.7 million as it transitioned from development to commercial operations in the US, securing FDA clearance and signing three foundation customers. An $80 million capital raise underpins its ambitious US expansion and ongoing product development.

Ironbark Balanced Income Limited reported a solid half-year profit increase of 14.6%, driven by strong portfolio returns and a strategic shift to quarterly dividends. The company declared a fully franked interim dividend of 1.3 cents per share payable in March 2026.

Service Stream Limited reported a 6.4% revenue decline for the half-year ending December 2025, yet delivered a 2.3% rise in underlying EBITDA and increased its interim dividend to 3 cents per share.

Saunders International reported a half-year loss for H1 FY2026 despite a 13.7% revenue increase driven by its acquisition of Aqua Metro. The company’s project pipeline expanded to a record $4.9 billion, signalling growth potential amid operational challenges.

X2M Connect Limited reported a 45% rise in revenue to $4.9 million for the half-year ended December 2025, driven by strong growth in South Korea and new contracts in Japan and Taiwan. Despite a modest increase in net loss, the company narrowed its adjusted EBITDA loss by 10%, supported by operational improvements and a $5.4 million capital raise.

Noumi Limited reported an 11.2% revenue increase and a 23.3% rise in adjusted operating EBITDA for H1 FY26, yet posted a $24.2 million net loss amid significant convertible notes repayment uncertainty.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

Vysarn Limited has reported a record first half for FY26 with revenue hitting $66.8 million and NPBT nearly doubling year-on-year to $10 million. The company reaffirms its full-year $20 million NPBT target, supported by strong industrial and advisory segment growth despite timing challenges in technology projects.

Lumos Diagnostics has hit a key enrollment milestone in its BARDA-funded paediatric study for FebriDx®, unlocking a US$720,000 payment and edging closer to FDA expansion.

A recent expert panel convened by Novitas has strongly endorsed Pacific Edge’s urine-based Cxbladder tests for hematuria evaluation, recommending Medicare coverage based on robust clinical evidence and patient care benefits.

Synertec Corporation has won operational technology contracts exceeding $1 million with Sydney Water, marking a significant step in its national expansion within Australia's water infrastructure sector.